Table 2.

Distribution and prevalence of CL in different age groups and gender for the years 2018 and 2019

Year	Age	n	(%)	Male			Female
				n	Positive (%)	P value	n	Positive (%)	P value
2018	0–9	368	38	214	97 (45.3)	0.258	154	72 (46.8)	0.481
	10–19	287	29.6	164	61 (37.2)		123	57 (46.3)
	20–29	122	12.6	72	25 (34.7)		50	20 (40.0)
	30–39	67	6.9	24	8 (33.3)		43	17 (39.5)
	40+	125	12.9	62	21 (33.9)		63	22 (34.9)
	Total	969		536	212 (39.6)		433	188 (43.4)
2019	0–9	1245	40.1	695	399 (57.4)	0.035	550	313 (56.9)	0.081
	10–19	895	28.8	510	270 (52.9)		385	205 (53.2)
	20–29	406	13.1	255	130 (51.0)		151	85 (56.3)
	30–39	202	6.5	102	48 (47.1)		100	45 (45.0)
	40+	355	11.4	173	80 (46.2)		182	87 (47.8)
	Total	3103		1735	927 (53.4)		1368	735 (53.7)